108 related articles for article (PubMed ID: 20064498)
1. Methylated cyclin D2 gene circulating in the blood as a prognosis predictor of hepatocellular carcinoma.
Tsutsui M; Iizuka N; Moribe T; Miura T; Kimura N; Tamatsukuri S; Ishitsuka H; Fujita Y; Hamamoto Y; Tsunedomi R; Iida M; Tokuhisa Y; Sakamoto K; Tamesa T; Sakaida I; Oka M
Clin Chim Acta; 2010 Apr; 411(7-8):516-20. PubMed ID: 20064498
[TBL] [Abstract][Full Text] [Related]
2. AFP mRNA detected in bone marrow by real-time quantitative RT-PCR analysis predicts survival and recurrence after curative hepatectomy for hepatocellular carcinoma.
Kamiyama T; Takahashi M; Nakagawa T; Nakanishi K; Kamachi H; Suzuki T; Shimamura T; Taniguchi M; Ozaki M; Matsushita M; Furukawa H; Todo S
Ann Surg; 2006 Sep; 244(3):451-63. PubMed ID: 16926571
[TBL] [Abstract][Full Text] [Related]
3. A three-gene predictor for early intrahepatic recurrence of hepatocellular carcinoma after curative hepatectomy.
Somura H; Iizuka N; Tamesa T; Sakamoto K; Hamaguchi T; Tsunedomi R; Yamada-Okabe H; Sawamura M; Eramoto M; Miyamoto T; Hamamoto Y; Oka M
Oncol Rep; 2008 Feb; 19(2):489-95. PubMed ID: 18202799
[TBL] [Abstract][Full Text] [Related]
4. [Expression of vascular endothelial growth factor (VEGF) family members and prognosis after hepatic resection in HBV-related hepatocellular carcinoma].
Moon JI; Kim JM; Jung GO; Chun JM; Choi GS; Park JB; Kwon CH; Kim SJ; Jo JW
Korean J Hepatol; 2008 Jun; 14(2):185-96. PubMed ID: 18617766
[TBL] [Abstract][Full Text] [Related]
5. Does the presence of circulating hepatocellular carcinoma cells indicate a risk of recurrence after resection?
Jeng KS; Sheen IS; Tsai YC
Am J Gastroenterol; 2004 Aug; 99(8):1503-9. PubMed ID: 15307868
[TBL] [Abstract][Full Text] [Related]
6. Clinical impact of plasma TGF-beta1 and circulating TGF-beta1 mRNA in diagnosis of hepatocellular carcinoma.
Dong ZZ; Yao DF; Yao M; Qiu LW; Zong L; Wu W; Wu XH; Yao DB; Meng XY
Hepatobiliary Pancreat Dis Int; 2008 Jun; 7(3):288-95. PubMed ID: 18522884
[TBL] [Abstract][Full Text] [Related]
7. Circulating messenger RNA of alpha-fetoprotein: a possible risk factor of recurrence after resection of hepatocellular carcinoma.
Jeng KS; Sheen IS; Tsai YC
Arch Surg; 2004 Oct; 139(10):1055-60. PubMed ID: 15492142
[TBL] [Abstract][Full Text] [Related]
8. Albumin mRNA in plasma predicts post-transplant recurrence of patients with hepatocellular carcinoma.
Cheung ST; Fan ST; Lee YT; Chow JP; Ng IO; Fong DY; Lo CM
Transplantation; 2008 Jan; 85(1):81-7. PubMed ID: 18192916
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of alpha-fetoprotein messenger RNA for early detection of recurrent hepatocellular carcinoma: a prospective pilot study.
Schmilovitz-Weiss H; Stemmer SM; Liberzon E; Avigad S; Sulkes J; Belinki A; Kazatsker A; Ben-Ari Z
Cancer Detect Prev; 2006; 30(2):204-9. PubMed ID: 16638626
[TBL] [Abstract][Full Text] [Related]
10. Quantitative analysis of multiple methylated genes in plasma for the diagnosis and prognosis of hepatocellular carcinoma.
Huang ZH; Hu Y; Hua D; Wu YY; Song MX; Cheng ZH
Exp Mol Pathol; 2011 Dec; 91(3):702-7. PubMed ID: 21884695
[TBL] [Abstract][Full Text] [Related]
11. Aberrant methylation of the CADM1 promoter is associated with poor prognosis in hepatocellular carcinoma treated with liver transplantation.
Zhang W; Zhou L; Ding SM; Xie HY; Xu X; Wu J; Chen QX; Zhang F; Wei BJ; Eldin AT; Zheng SS
Oncol Rep; 2011 Apr; 25(4):1053-62. PubMed ID: 21271221
[TBL] [Abstract][Full Text] [Related]
12. Preoperative plasma transcript AA454543 level is an independent prognostic factor for hepatocellular carcinoma after partial hepatectomy.
Cheung ST; Liu CL; Chow JP; Lee YT; Ip YC; Ho JC; Fan ST
Neoplasia; 2006 Sep; 8(9):696-701. PubMed ID: 16984726
[TBL] [Abstract][Full Text] [Related]
13. The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma.
Hashimoto K; Ikeda Y; Korenaga D; Tanoue K; Hamatake M; Kawasaki K; Yamaoka T; Iwatani Y; Akazawa K; Takenaka K
Cancer; 2005 May; 103(9):1856-64. PubMed ID: 15779015
[TBL] [Abstract][Full Text] [Related]
14. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
15. High serum levels of vascular endothelial growth factor after hepatectomy are associated with poor prognosis in hepatocellular carcinoma.
Tamesa T; Iizuka N; Mori N; Okada T; Takemoto N; Tangoku A; Oka M
Hepatogastroenterology; 2009; 56(93):1122-6. PubMed ID: 19760954
[TBL] [Abstract][Full Text] [Related]
16. [The detection of circulating hepatocellular carcinoma cells in peripheral venous blood by reverse transcription-polymerase chain reaction and its clinical significance].
Liu Y; Zhang B; Qian G; Chen H; Wu M; Fu J; Huang C
Zhonghua Wai Ke Za Zhi; 1998 Oct; 36(10):608-10. PubMed ID: 11825477
[TBL] [Abstract][Full Text] [Related]
17. Serum human telomerase reverse transcriptase messenger RNA as a novel tumor marker for hepatocellular carcinoma.
Miura N; Maeda Y; Kanbe T; Yazama H; Takeda Y; Sato R; Tsukamoto T; Sato E; Marumoto A; Harada T; Sano A; Kishimoto Y; Hirooka Y; Murawaki Y; Hasegawa J; Shiota G
Clin Cancer Res; 2005 May; 11(9):3205-9. PubMed ID: 15867214
[TBL] [Abstract][Full Text] [Related]
18. Quantitative analysis of apoptosis-related gene expression in hepatocellular carcinoma.
Ikeguchi M; Hirooka Y; Kaibara N
Cancer; 2002 Nov; 95(9):1938-45. PubMed ID: 12404288
[TBL] [Abstract][Full Text] [Related]
19. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
[TBL] [Abstract][Full Text] [Related]
20. Quantitative analysis of tumor-derived methylated p16INK4a sequences in plasma, serum, and blood cells of hepatocellular carcinoma patients.
Wong IH; Zhang J; Lai PB; Lau WY; Lo YM
Clin Cancer Res; 2003 Mar; 9(3):1047-52. PubMed ID: 12631605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
